Inventor · disambiguated record
Michael R. Mish
Also filed as: MISH MICHAEL · MISH MICHAEL R
22 granted patents·18 pending applications·301 citations·filing 2005–2025
95Inventor score
Top patents by PatentIndex Score
40 records- 0198US10640499B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2017·Granted May 5, 2020·32 cites·10 claims
- 0298US10370342B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2017·Granted Aug 6, 2019·30 cites·13 claims
- 0398US9670205B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2016·Granted Jun 6, 2017·100 cites·16 claims
- 0497US11827609B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2021·Granted Nov 28, 2023·4 cites·11 claims
- 0596US11179397B2Imidazopyrimidine derivativesGILEAD SCIENCES INC·Filed 2019·Granted Nov 23, 2021·23 cites·13 claims
- 0696US10285990B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2017·Granted May 14, 2019·11 cites·6 claims
- 0796US8877733B21′-substituted pyrimidine N-nucleoside analogs for antiviral treatmentCHO AESOP·Filed 2012·Granted Nov 4, 2014·55 cites·30 claims
- 0893US10035809B2Substituted 2,3,4,5,7,9,13,13a-octahydro-1,5-methanopyrido[1′,2′:4,5]pyrazino[1,2-a][1,3]diazepines and methods for treating viral infectionsGILEAD SCIENCES INC·Filed 2017·Granted Jul 31, 2018·10 cites·3 claims
- 0992US12091420B2SARS-COV2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Sep 17, 2024·3 cites·28 claims
- 1092US11124487B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2019·Granted Sep 21, 2021·8 cites·14 claims
- 1190US12410183B2Sars-cov2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2024·Granted Sep 9, 2025·1 cites·25 claims
- 1289US9458145B2Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Oct 4, 2016·12 cites·9 claims
- 1388US10689399B2Substituted 3,4,5,6,8,10,14,14a-octahydro-2h-2,6-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazocines and methods for treating viral infectionsGILEAD SCIENCES INC·Filed 2018·Granted Jun 23, 2020·2 cites·4 claims
- 1483US9255089B2Benzimidazolone derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Feb 9, 2016·7 cites·19 claims
- 1577US12377100B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2021·Granted Aug 5, 2025·0 cites·5 claims
- 1676US2025002513A1Antiviral compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1775US11919869B2CD73 compoundsGILEAD SCIENCES INC·Filed 2022·Granted Mar 5, 2024·0 cites·27 claims
- 1875US2024279186A1Cd73 compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1975US2024239807A1Sars-cov2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 2074US11548901B2Substituted 1,4-methanopyrido[1′,2′:4,5]pyrazino[1,2-a]pyrimidines for treating viral infectionsGILEAD SCIENCES INC·Filed 2020·Granted Jan 10, 2023·0 cites·21 claims
- 2174US8008287B2Integrase inhibitorsGILEAD SCIENCES INC·Filed 2007·Granted Aug 30, 2011·2 cites·52 claims
- 2274US2023295201A1Antiviral compoundsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 2372US7998950B2Antiviral compoundsGILEAD SCIENCES INC·Filed 2009·Granted Aug 16, 2011·1 cites·17 claims
- 2468US2025129051A1Parp1 inhibitors and uses thereofGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2568US2025270174A1Cd73 compoundsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 2667US2025230168A1Azaspiro wrn inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2765US2022241281A1Imidazopyrimidine DerivativesGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2864US12110294B2CD73 compoundsGILEAD SCIENCES INC·Filed 2021·Granted Oct 8, 2024·0 cites·7 claims
- 2964US2024116928A1Cd73 compoundsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 3063US12030903B2Antiviral compoundsGILEAD SCIENCES INC·Filed 2021·Granted Jul 9, 2024·0 cites·33 claims
- 3162US2019282576A1Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2019·Application pending·0 cites
- 3261US2022356196A1Antiviral compoundsGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 3355US2018282316A1Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 3454US2008076740A1Antiviral compoundsGILEAD SCIENCES INC·Filed 2006·Application pending·0 cites
- 3552US10017501B2Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted Jul 10, 2018·0 cites·15 claims
- 3650US2009291921A1Integrase inhibitorsGILEAD SCIENCES INC·Filed 2008·Application pending·0 cites
- 3744US2008076738A1Phosphonate Analogs Of Hiv Integrase Inhibitor CompoundsCAI ZHENHONG R·Filed 2005·Application pending·0 cites
- 3844US2006116356A1Phosphonate analogs of HIV integrase inhibitor compoundsCAI ZHENHONG R·Filed 2005·Application pending·0 cites
- 3941US2007072831A1Integrase inhibitor compoundsGILEAD SCIENCES INC·Filed 2006·Application pending·0 cites
- 4034US2012053148A1Inhibitors of hepatitis c virusCAI ZHENHONG R·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael R. Mish files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →